NasdaqGM:SEPNPharmaceuticals
Septerna (SEPN) Q1 Loss Narrows To US$8.6 Million Challenging Bearish Earnings Narratives
Q1 2026 earnings snapshot
Septerna (SEPN) opened 2026 with Q1 revenue of US$26.5 million and a basic EPS loss of US$0.19, as net income excluding extra items came in at a loss of US$8.6 million, against a trailing twelve month loss of US$36.0 million on US$72.3 million of revenue. The company has seen quarterly revenue move from US$0.2 million in Q1 2025 to US$26.5 million in Q1 2026, while basic EPS has shifted from a loss of US$0.49 to a loss of US$0.19 over the same period. This frames a...